Cargando…

Dynamic changes in circulating T follicular helper cell composition predict neutralising antibody responses after yellow fever vaccination

OBJECTIVES: T follicular helper (Tfh) cells are the principal T helper cell subset that provides help to B cells for potent antibody responses against various pathogens. In this study, we took advantage of the live‐attenuated yellow fever virus (YFV) vaccine strain, YF‐17D, as a model system for stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Huber, Johanna E, Ahlfeld, Julia, Scheck, Magdalena K, Zaucha, Magdalena, Witter, Klaus, Lehmann, Lisa, Karimzadeh, Hadi, Pritsch, Michael, Hoelscher, Michael, von Sonnenburg, Frank, Dick, Andrea, Barba‐Spaeth, Giovanna, Krug, Anne B, Rothenfußer, Simon, Baumjohann, Dirk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7221214/
https://www.ncbi.nlm.nih.gov/pubmed/32419947
http://dx.doi.org/10.1002/cti2.1129
_version_ 1783533324284723200
author Huber, Johanna E
Ahlfeld, Julia
Scheck, Magdalena K
Zaucha, Magdalena
Witter, Klaus
Lehmann, Lisa
Karimzadeh, Hadi
Pritsch, Michael
Hoelscher, Michael
von Sonnenburg, Frank
Dick, Andrea
Barba‐Spaeth, Giovanna
Krug, Anne B
Rothenfußer, Simon
Baumjohann, Dirk
author_facet Huber, Johanna E
Ahlfeld, Julia
Scheck, Magdalena K
Zaucha, Magdalena
Witter, Klaus
Lehmann, Lisa
Karimzadeh, Hadi
Pritsch, Michael
Hoelscher, Michael
von Sonnenburg, Frank
Dick, Andrea
Barba‐Spaeth, Giovanna
Krug, Anne B
Rothenfußer, Simon
Baumjohann, Dirk
author_sort Huber, Johanna E
collection PubMed
description OBJECTIVES: T follicular helper (Tfh) cells are the principal T helper cell subset that provides help to B cells for potent antibody responses against various pathogens. In this study, we took advantage of the live‐attenuated yellow fever virus (YFV) vaccine strain, YF‐17D, as a model system for studying human antiviral immune responses in vivo following exposure to an acute primary virus challenge under safe and highly controlled conditions, to comprehensively analyse the dynamics of circulating Tfh (cTfh) cells. METHODS: We tracked and analysed the response of cTfh and other T and B cell subsets in peripheral blood of healthy volunteers by flow cytometry over the course of 4 weeks after YF‐17D vaccination. RESULTS: Using surface staining of cell activation markers to track YFV‐specific T cells, we found increasing cTfh cell frequencies starting at day 3 and peaking around 2 weeks after YF‐17D vaccination. This kinetic was confirmed in a subgroup of donors using MHC multimer staining for four known MHC class II epitopes of YF‐17D. The subset composition of cTfh cells changed dynamically during the course of the immune response and was dominated by the cTfh1‐polarised subpopulation. Importantly, frequencies of cTfh1 cells correlated with the strength of the neutralising antibody response, whereas frequencies of cTfh17 cells were inversely correlated. CONCLUSION: In summary, we describe detailed cTfh kinetics during YF‐17D vaccination. Our results suggest that cTfh expansion and polarisation can serve as a prognostic marker for vaccine success. These insights may be leveraged in the future to improve current vaccine design and strategies.
format Online
Article
Text
id pubmed-7221214
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-72212142020-05-15 Dynamic changes in circulating T follicular helper cell composition predict neutralising antibody responses after yellow fever vaccination Huber, Johanna E Ahlfeld, Julia Scheck, Magdalena K Zaucha, Magdalena Witter, Klaus Lehmann, Lisa Karimzadeh, Hadi Pritsch, Michael Hoelscher, Michael von Sonnenburg, Frank Dick, Andrea Barba‐Spaeth, Giovanna Krug, Anne B Rothenfußer, Simon Baumjohann, Dirk Clin Transl Immunology Original Articles OBJECTIVES: T follicular helper (Tfh) cells are the principal T helper cell subset that provides help to B cells for potent antibody responses against various pathogens. In this study, we took advantage of the live‐attenuated yellow fever virus (YFV) vaccine strain, YF‐17D, as a model system for studying human antiviral immune responses in vivo following exposure to an acute primary virus challenge under safe and highly controlled conditions, to comprehensively analyse the dynamics of circulating Tfh (cTfh) cells. METHODS: We tracked and analysed the response of cTfh and other T and B cell subsets in peripheral blood of healthy volunteers by flow cytometry over the course of 4 weeks after YF‐17D vaccination. RESULTS: Using surface staining of cell activation markers to track YFV‐specific T cells, we found increasing cTfh cell frequencies starting at day 3 and peaking around 2 weeks after YF‐17D vaccination. This kinetic was confirmed in a subgroup of donors using MHC multimer staining for four known MHC class II epitopes of YF‐17D. The subset composition of cTfh cells changed dynamically during the course of the immune response and was dominated by the cTfh1‐polarised subpopulation. Importantly, frequencies of cTfh1 cells correlated with the strength of the neutralising antibody response, whereas frequencies of cTfh17 cells were inversely correlated. CONCLUSION: In summary, we describe detailed cTfh kinetics during YF‐17D vaccination. Our results suggest that cTfh expansion and polarisation can serve as a prognostic marker for vaccine success. These insights may be leveraged in the future to improve current vaccine design and strategies. John Wiley and Sons Inc. 2020-05-13 /pmc/articles/PMC7221214/ /pubmed/32419947 http://dx.doi.org/10.1002/cti2.1129 Text en © 2020 The Authors. Clinical & Translational Immunology published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology, Inc. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Huber, Johanna E
Ahlfeld, Julia
Scheck, Magdalena K
Zaucha, Magdalena
Witter, Klaus
Lehmann, Lisa
Karimzadeh, Hadi
Pritsch, Michael
Hoelscher, Michael
von Sonnenburg, Frank
Dick, Andrea
Barba‐Spaeth, Giovanna
Krug, Anne B
Rothenfußer, Simon
Baumjohann, Dirk
Dynamic changes in circulating T follicular helper cell composition predict neutralising antibody responses after yellow fever vaccination
title Dynamic changes in circulating T follicular helper cell composition predict neutralising antibody responses after yellow fever vaccination
title_full Dynamic changes in circulating T follicular helper cell composition predict neutralising antibody responses after yellow fever vaccination
title_fullStr Dynamic changes in circulating T follicular helper cell composition predict neutralising antibody responses after yellow fever vaccination
title_full_unstemmed Dynamic changes in circulating T follicular helper cell composition predict neutralising antibody responses after yellow fever vaccination
title_short Dynamic changes in circulating T follicular helper cell composition predict neutralising antibody responses after yellow fever vaccination
title_sort dynamic changes in circulating t follicular helper cell composition predict neutralising antibody responses after yellow fever vaccination
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7221214/
https://www.ncbi.nlm.nih.gov/pubmed/32419947
http://dx.doi.org/10.1002/cti2.1129
work_keys_str_mv AT huberjohannae dynamicchangesincirculatingtfollicularhelpercellcompositionpredictneutralisingantibodyresponsesafteryellowfevervaccination
AT ahlfeldjulia dynamicchangesincirculatingtfollicularhelpercellcompositionpredictneutralisingantibodyresponsesafteryellowfevervaccination
AT scheckmagdalenak dynamicchangesincirculatingtfollicularhelpercellcompositionpredictneutralisingantibodyresponsesafteryellowfevervaccination
AT zauchamagdalena dynamicchangesincirculatingtfollicularhelpercellcompositionpredictneutralisingantibodyresponsesafteryellowfevervaccination
AT witterklaus dynamicchangesincirculatingtfollicularhelpercellcompositionpredictneutralisingantibodyresponsesafteryellowfevervaccination
AT lehmannlisa dynamicchangesincirculatingtfollicularhelpercellcompositionpredictneutralisingantibodyresponsesafteryellowfevervaccination
AT karimzadehhadi dynamicchangesincirculatingtfollicularhelpercellcompositionpredictneutralisingantibodyresponsesafteryellowfevervaccination
AT pritschmichael dynamicchangesincirculatingtfollicularhelpercellcompositionpredictneutralisingantibodyresponsesafteryellowfevervaccination
AT hoelschermichael dynamicchangesincirculatingtfollicularhelpercellcompositionpredictneutralisingantibodyresponsesafteryellowfevervaccination
AT vonsonnenburgfrank dynamicchangesincirculatingtfollicularhelpercellcompositionpredictneutralisingantibodyresponsesafteryellowfevervaccination
AT dickandrea dynamicchangesincirculatingtfollicularhelpercellcompositionpredictneutralisingantibodyresponsesafteryellowfevervaccination
AT barbaspaethgiovanna dynamicchangesincirculatingtfollicularhelpercellcompositionpredictneutralisingantibodyresponsesafteryellowfevervaccination
AT kruganneb dynamicchangesincirculatingtfollicularhelpercellcompositionpredictneutralisingantibodyresponsesafteryellowfevervaccination
AT rothenfußersimon dynamicchangesincirculatingtfollicularhelpercellcompositionpredictneutralisingantibodyresponsesafteryellowfevervaccination
AT baumjohanndirk dynamicchangesincirculatingtfollicularhelpercellcompositionpredictneutralisingantibodyresponsesafteryellowfevervaccination